Menu
ETF
Annual · values20252024202320222021202020192018
Operating Cash Flow-60.38 M USD-36.71 M USD-47.46 M USD-107.43 M USD-39.07 M USD-19.37 M USD-5.52 M USD-3.67 M USD
Depreciation & Amortization53000 USD35000 USD
Stock-Based Compensation16.25 M USD115000 USD
Capital Expenditures125000 USD73000 USD
Cash Flow from Investing-125000 USD-73000 USD
Cash Flow from Financing13.86 M USD3.68 M USD
Dividends Paid
Stock Buybacks
Free Cash Flow-45.00 M USD-39.37 M USD-48.08 M USD-50.56 M USD-61.22 M USD-35.55 M USD-5.65 M USD-3.74 M USD

Nano-X Imaging Ltd. is a medical imaging company known for its innovative approach to diagnostic technologies. It focuses on developing and commercializing novel X-ray systems designed to improve access to medical imaging and enhance healthcare delivery worldwide. A significant feature of Nano-X Imaging's technology is the "Nanox.ARC," a digital X-ray system that aims to integrate next-generation imaging capabilities with artificial intelligence to facilitate early disease detection. This system is complemented by the "Nanox.CLOUD," a cloud-based software platform intended to provide imaging analytics and management tools to healthcare providers. The company's efforts are geared towards addressing the limitations of traditional radiography solutions, such as high costs and complex infrastructure needs. By making advanced imaging more accessible and affordable, Nano-X Imaging Ltd. could play a pivotal role in transforming medical diagnostics, particularly in underserved regions, contributing significantly to global health initiatives and the medical devices sector.